Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2010; 16(38): 4871-4875
Published online Oct 14, 2010. doi: 10.3748/wjg.v16.i38.4871
Published online Oct 14, 2010. doi: 10.3748/wjg.v16.i38.4871
Experimental group | Control group | P value | |
Age (yr) | 57.72 ± 10.39 | 58.68 ± 11.73 | 0.779 |
Women, n (%) | 5 (28) | 9 (32) | 0.754 |
Size of abscess before therapy (diameter) | 7.22 ± 1.44 | 8.01 ± 2.63 | 0.291 |
Size of abscess after therapy (diameter) | 3.64 ± 0.89 | 4.02 ± 1.77 | 0.484 |
Antibiotic treatment before percutaneous drainage (d) | 7.22 ± 5.39 | 6.82 ± 4.59 | 0.788 |
Antibiotic treatment after percutaneous drainage (d) | 15.83 ± 6.45 | 24.25 ± 8.18 | 0.0011 |
Duration of follow-up (mo) | 9.25 ± 5.67 | 9.24 ± 4.94 | 0.995 |
Recurrence rate | 0% | 11% (follow-up information for 3 individuals was not obtained) | 0.151 |
Total duration of antibiotic treatment (d) | 23.06 ± 7.36 | 31.11 ± 7.30 | 0.0011 |
- Citation: Gao HN, Yuan WX, Yang MF, Zhao H, Hu JH, Zhang X, Fan J, Ma WH. Clinical significance of C-reactive protein values in antibiotic treatment for pyogenic liver abscess. World J Gastroenterol 2010; 16(38): 4871-4875
- URL: https://www.wjgnet.com/1007-9327/full/v16/i38/4871.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i38.4871